Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07054593 · ClinicalTrials.gov registry record · Phase 1
Effect of Proton Pump Inhibitors on Gut Microbiota Composition and Metabolites in Healthy Subjects Using CapScan
A Phase 1 study, sponsored by Envivo Bio.
- Not yet
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT07054593 is a Phase 1 study that has not yet begun recruiting, run by Envivo Bio. The registered enrollment target is 44 participants.
The verdict
NCT07054593, a Phase 1 study, has not yet begun recruiting, sponsored by Envivo Bio.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study is designed to evaluate the effect of proton pump inhibitors on the regional composition of the gut microbiota and metabolic profiles of health volunteers using the CapScan collection capsule.
Interventions
- DEVICE CapScan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-07-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07054593
The ClinicalTrials.gov registry entry for NCT07054593 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Envivo Bio, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CapScan is the first listed.
NCT07054593 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07054593 about?
NCT07054593 is a clinical study titled "Effect of Proton Pump Inhibitors on Gut Microbiota Composition and Metabolites in Healthy Subjects Using CapScan". This study is designed to evaluate the effect of proton pump inhibitors on the regional composition of the gut microbiota and metabolic profiles of health volunteers using the CapScan collection capsule.
What is the current status of trial NCT07054593?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2025-12-01. Estimated completion is 2026-07-31.
What interventions are being tested in trial NCT07054593?
The interventions under investigation include: CapScan (DEVICE).
Who is sponsoring clinical trial NCT07054593?
This trial is sponsored by Envivo Bio, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.